PCG Stock Recent News
PCG LATEST HEADLINES
CNBC's Jane Fraser reports on the company's quarterly earnings results.
PG&E (PCG) reported total revenues of $7,041 million compared with $5,370 million in the year-ago period. Operating revenues also beat the Zacks Consensus Estimate by 9.5%.
PG&E (PCG) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.26 per share a year ago.
PG&E's (PCG) Q4 results are likely to reflect favorable weather pattern impact and benefits of lower non-fuel operating and maintenance expenses.
CNBC found evidence of safety shortcomings in the public utility sector and a lack of state oversight.
Bay Area rooftop-solar businesses are reeling from a statewide change that gutted compensation for homeowners returning surplus power to the electrical grid, causing applications for new solar to plunge to a 10-year low and leading to layoffs in an industry that had expected to lead the vanguard toward more sustainable, environmentally friendly energy use.
PG&E CEO Patti Poppe joins 'Money Movers' to discuss the company's wildfire risk, the use of generative AI in wildfire modeling, and more.
This summer's Oppenheimer movie reinvigorated the public imagination for nuclear energy opportunity, but the energy industry has been quietly moving toward it for years now. It closely linked the resurgence of nuclear to global efforts to combat climate change and a strategic need for Europe to reduce its dependence on Russian oil and gas imports.
Shares of PG&E Corp. PCG powered up 2% toward a four-year high in premarket trading Tuesday, after the California-based gas and electric utility said it was reinstating its dividend. The company said shareholders of record on Dec. 29 will receive a penny for each share they own on Jan. 15.
PG&E (NYSE: PCG ) electricity customers in California, get ready for some major sticker shock. State regulators just approved a spending bill that will enable price hikes in your upcoming PG&E bills.